← FDA Drug Approvals (Drugs@FDA)
EMTRICITABINE; TENOFOVIR ALAFENAMIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA · Approved 2022-12-19
Drug application
- FDA Application #
ANDA216875- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- EMTRICITABINE; TENOFOVIR ALAFENAMIDE
- Generic name
- Emtricitabine
- Active ingredients
- EMTRICITABINE; TENOFOVIR ALAFENAMIDE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- AUROBINDO PHARMA
- First approval
- 2022-12-19
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown